San Jose BioCenter
San Jose BioCenter's home page
Financial Darwinism: Which Companies are the Fittest?
 
Orrick, Herrington & Sutcliffe LLP
1000 Marsh Road
Menlo Park, CA 94025-1015
Tuesday, Sep. 22, 2009
3:00 PM  - 6:30 PM
Details
Financial Darwinism:  Which Companies are the Fittest?

Tuesday, September 22, 2008 | 3pm-6:30pm
An Industry Panel and Networking Reception

Agenda
3:00 - 3:30 PM Registration and Networking
3:30 - 5:00 PM Panel
5:00 - 6:30 PM Networking Reception

Modern evolution theory suggests only the fittest will survive; in the business world, we know this to be fact. Find out what it takes to prepare your company for survival. Join this panel to hear survival tips from VC investors, and what they look for in an investment.

Confirmed Panelists
  • Peter McWilliams, Principal, Sanderling Ventures
  • Bob Ward, Principal, Kaiser Permanente Ventures
  • Mark Barrett, Director, Business Development, Johnson & Johnson
  • Mark Schwartz, Ph.D., President & CEO, Bayhill Therapeutics
  • Lead Facilitator: Scott M. Iyama, Corporate Lawyer, Emerging Companies Group Member, Orrick, Herrington & Sutcliffe LLP

    • Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Networking Reception.

    Not Available for Booking
    This activity has already ended.



    San Jose BioCenter Purchase/refund policy: SORRY, ALL TICKET SALES ARE FINAL.

    Acteva's Purchase/refund policy: Refunds and cancellations are provided only at the discretion of the organization hosting or sponsoring this event. Acteva.com issues credits only when directed to do so by the sponsoring organization. Contact refunds@acteva.com or the sponsoring organization for further details.



    Accelerating the commercialization of science, the San Jose BioCenter provides
    a new generation of specialized facilities; capital equipment; lab services;
    and commercialization support for emerging science and technology companies.
    The BioCenter is a new, time and cost efficient model to
    commercialize innovation for emerging science and technology companies.
    Since inception, the life science and clean technology companies of
    the BioCenter have raised more than $1B in deals and financing,
    and have created more than 600 direct jobs.

    Giving emerging companies that Big Company Advantage...

    This event was published with the Internet's Leading Online Event Registration and Payment Solution - Acteva. Increase participation, reduce administrative costs and make more money on events of all kinds with Acteva.
    Acteva's Home Page Security Acteva Privacy Policy Questions Contact Acteva